New Dual-Scope surgery shows promise for early stomach cancer
NCT ID NCT07615374
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new surgery for early gastric cancer that uses two scopes (a laparoscope and an endoscope) to guide the removal of sentinel lymph nodes. The goal is to see if this approach is safe and effective. The study involves 36 people with early-stage stomach cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
the First Hospital of Jilin University
Ch’ang-ch’un, Jilin, 130021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which treatment for early stomach cancer offers the best Long-Term survival?
- Stomach bug clues: can infection patterns forecast early cancer behavior?
- Fluorescent dye guides Stomach-Sparing surgery for early cancer
- AI could help endoscopists catch stomach cancer earlier
- New laser probe could spot stomach cancer earlier than biopsy
- Robot vs. laparoscope: which surgery is safer for early stomach cancer?